8 Sep 2020

Nab Paclitaxel (Albumin Bound)

Murli Krishna Pharma is one of the few companies from India who have developed Albumin bound Paclitaxel. The particle size and the encapsulation efficiency have matched with the innovator’s specifications. In Vitro Cell line studies have shown that the activity is comparable to the innovator.

Content provided by our supplier

Murli Krishna Pharma Pvt Ltd

  • IN
  • 2016
    On CPHI since
  • 2
  • 250 - 499
Company types

Other Content from Murli Krishna Pharma Pvt Ltd (2)